Argent Trades medical cannabis Rights to Splash in $5.5M Deal
medical cannabis: Argent sells global CannEpil rights to Splash Beverage for US$5.5M, clears ~60% convertible debt, retains IP and 15% worldwide royalty.
Tag: pharmaceuticals
Winston-Salem Seeks medical cannabis Research Hub
Wake Forest-backed Winston-Salem seeks medical cannabis research role, surveys centuries of therapeutic use, FDA cannabinoid drugs, and federal barriers.
DanCann, Phytanix, and Sandoz Announce Key Cannabis Developments
The European cannabis sector is experiencing notable activity as companies like DanCann, Phytanix, and Sandoz make significant announcements. This surge…